Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) EBT Margin (2018 - 2025)

Dna X's EBT Margin history spans 8 years, with the latest figure at 28.76% for Q3 2025.

  • Quarterly results put EBT Margin at 28.76% for Q3 2025, down 1282.0% from a year ago — trailing twelve months through Dec 2025 was 18.03% (down 1366.0% YoY), and the annual figure for FY2024 was 4.95%, down 570.0%.
  • EBT Margin for Q3 2025 was 28.76% at Dna X, up from 65.56% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 39.18% in Q4 2024 to a low of 75.32% in Q1 2021.
  • The 5-year median for EBT Margin is 16.58% (2024), against an average of 27.47%.
  • The sharpest move saw EBT Margin soared 6957bps in 2022, then tumbled -5929bps in 2024.
  • Year by year, EBT Margin stood at 73.96% in 2021, then skyrocketed by 94bps to 4.39% in 2022, then plummeted by -42bps to 6.22% in 2023, then skyrocketed by 730bps to 39.18% in 2024, then plummeted by -173bps to 28.76% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 28.76%, 65.56%, and 3.53% for Q3 2025, Q2 2025, and Q1 2025 respectively.